Okay, let's tackle this question about the treatment of medullary carcinoma of the thyroid with lymph node metastasis. First, I need to recall the basics of medullary thyroid cancer (MTC). MTC arises from the parafollicular C cells, which produce calcitonin. Unlike other thyroid cancers like papillary or follicular, MTC doesn't take up radioactive iodine, so treatment approaches differ.

The core concept here is the surgical management of MTC, especially when there's lymph node involvement. The main treatment is surgery, aiming for complete resection. The standard procedure is a total thyroidectomy with central lymph node dissection. This is because MTC has a high propensity for early lymphatic spread, particularly to the central neck nodes. So, removing these nodes helps in staging and reduces the tumor burden.

Now, the correct answer should be the surgical option that includes total thyroidectomy and central neck dissection. Let's think about the options. If the options include total thyroidectomy with central node dissection, that's the right choice. Other options might suggest radioactive iodine, which isn't effective here because MTC cells don't express the sodium-iodide symporter. Chemotherapy or targeted therapies like tyrosine kinase inhibitors (e.g., vandetanib) are used in advanced cases but not first-line for resectable disease with lymph node metastasis.

The wrong options would likely include radioactive iodine (A), which is used for differentiated thyroid cancers but not MTC. Another might be subtotal thyroidectomy (B), which isn't sufficient as MTC is multifocal and requires total removal. Option C could be a lateral neck dissection alone, but central nodes are the first site of spread, so central dissection is essential. Option D might be watchful waiting or adjuvant therapy without surgery, which is incorrect because surgery is the primary treatment.

Clinical pearls to remember: Medullary thyroid cancer doesn't respond to radioactive iodine. Surgical resection with central lymph node dissection is the cornerstone. Also, testing for RET proto-oncogene mutations is important for hereditary cases (like MEN2) to guide treatment and screening of family members.

So, putting it all together, the correct answer would be the one that mentions total thyroidectomy plus central lymph node dissection. The other options are either for different types of thyroid cancer or inadequate for MTC's spread pattern.

**Core Concept**
Medullary carcinoma of the thyroid (MTC) arises from parafollicular C cells and is characterized by early lymphatic spread. Unlike differentiated thyroid cancers, it does not concentrate iodine, making **surgical resection** the primary treatment, with **central lymph node dissection** critical for staging and management.

**Why the Correct Answer is Right**
The standard treatment for MTC with lymph node metastasis is **total thyroidectomy with central compartment (level VI) lymph node dissection**. This approach removes all thyroid tissue and regional lymph nodes where MTC commonly spreads, reducing local recurrence and facilitating accurate staging. Additional lateral neck dissection (levels II–V) is reserved for clinically evident lateral node metastases.

**Why Each Wrong Option is Incorrect**
**Option A:** Radioactive iodine is ineffective for MTC, as C cells lack the sodium-iodide symporter required for uptake.
**Option B:** Subtotal thyroidectomy is

✓ Correct Answer: D. Total thyroidectomy + Radiotherapy